Presentation title - SE KIT : Home Page

Download Report

Transcript Presentation title - SE KIT : Home Page

Update on CCG Intelligence Programme, Delivery of
DMICs & links with Local Public Health
Helen Brown
South East Public Health
Knowledge and Information
Workshop
Thursday 25 October
Contact:
[email protected]
Objective
1. CCG intelligence requirements
o The Commissioning Intelligence model
(CIM)
2. Proposed Delivery Model & whole system working
3. Early thoughts on Public health data flows
4. Development and Delivery of DMICs
5. Suggested links between LA PH & DMICs
Vision & Headlines of CCG Intelligence Programme
o
The programme started out to understand the
commissioning Intelligence requirements for CCGs
from a bottom up approach
o
It involves strong clinical leadership to drive the
national vision for intelligence to enable large scale
health improvement for patients
o
We are co-designing the CCG Intelligence Delivery
Model
o
Support the CCG authorisation and CSS assurance
processes
o
Facilitate the sharing of current intelligence solutions
and tools
o
Advice and support to develop one version of the truth
shared across the patient journey and beyond
How LAs and CCGs will use intelligence to commission services
There are a
number of local
groups which need
local Intelligence
Non-Health
Local Authority Business Intelligence
Local Authorities are
accountable for providing
a Public Health advice
service & other
intelligence to support
other wider LA agendas
Public Health
Local Authority Business
Intelligence
Integrated
Commissioning
Health & Wellbeing
Boards
Other Local
Partnerships
CCG
Local Commissioning Intelligence
CCGs are accountable
for commissioning
services on the basis
of the best available
evidence
CCG NHS CB National Commissioning
Intelligence
LAs and CCGs
will need to use
the same common
data when
producing this
intelligence
There is an opportunity to use the same version of the truth.
4
CCG intelligence requirements - The Commissioning Intelligence Model
The CIM Model is a consolidated view of the different types of commissioning
intelligence requirements needed to support evidence based commissioning
decisions.
It takes account of feedback from a large scale engagement exercise including
innovative practice from across the country
We need:
Overarching
Question
o Streamlined data flows, store data
once and use many times
o Increased sharing of data to enable
greater understanding of the whole
system
An example
question
What will it do for CCGs?
o Greater understanding of the
potential and scope of intelligence
o Facilitate understanding of whole
system & evidence interdependencies
Data and
Tools
Overarching
concepts
Services
5
Joint Intelligence Programme Work
Public Health
England K&I
The Commissioning Intelligence Model
Types of Services
Tools/Data
Types of Services
S8.01: Demographic forecasting & disease trends (Provenance:
D8.01: Programme budgeting (comparative spend on
disease conditions) & marginal analysis, PBMA Atlas,
SPOT, SHAPE (Provenance: HB)
D8.02: Health investment packs, QIPP (Provenance: HB)
S1.01: Health needs / Joint Strategic Needs Assessment/
Impact assessments (data & analytical input) (Provenance: AF/WS290911)
HB)
S8.04: Forecasting and future projections of expected
activity. (Provenance: HB)
S8.05: Cost Benefits analysis of current activity vs.
alternatives (Provenance: HB)
S8.06: Strategic secondary analysis of 'How Healthy' and
'How much?' (Provenance: HB)
D8.03: Pathway modelling inc ROI calculators, return
on investment tools (Provenance: HB)
D8.04: Results and secondary analysis of other
questions, design making support etc (Provenance: HB)
D8.05: Quality of life & well being measures e.g.
QALYs (Provenance: CH181011)
D8.06: DH Programme Budgeting tool / Spend and
Outcome Tool (Provenance: CH181011)
S8.07: Track and react to patient expectation (Provenance: HB)
S8.08: Manage Programme Portfolio (Provenance: CH181011)
S8.09: Programme budgeting (comparative spend on
disease conditions) (Provenance: CH181011)
D8.07: Patient expectation information (Provenance: CH181011)
Tools/Data
D1.01: Population, migration, birth,
mortality and morbidity statistics and
projections (ONS, Exeter, QOF, Primary
Care, SUS, Prevalence modelling tools,
Census) (Provenance: AF/WS290911)
D1.02: Public Health Data Observatory /
Local Information Systems / JSNA / Cancer
Registry / Qualitative Data inc Voluntary &
Third sector (Provenance: AF/HBWS290911)
D1.03: Risk Stratification tools and models:
Patients at Risk of Readmission (PARR),
Combined Predictive Model, Adjusted
Clinical Groups. (Provenance: AF)
D1.04: Socio-demographic classification
system (e.g. Mosaic, Health foundations DH segmentation tool). (Provenance: AF/WS290911)
D1.05: Mapping and geo-spatial software
S1.02: Risk profiling & prediction. (Provenance: AF)
S1.03: Demographic forecasting & disease trends.
(Provenance: AF)
S1.05: Geographic analysis and mapping, socio-demographic
analysis. (Provenance: AF/HB)
S1.06: Identification of at-risk groups (e.g. Communities (inc
Travellers), Carers etc) (Provenance: Auth)
S1.07: Informing the public about keeping healthy,
prevention resources (Provenance: HB/CH)
S1.08: Research, surveys, audits, peer reviews (Provenance: HB/
WS290911)
S1.09: Managing needs of Stakeholders (e.g. Care Home,
Community, Health Education) (Provenance: WS290911)
D1.06: Deprivation indices (Index of
Multiple Deprivation). (Provenance: AF)
D1.07: Access to and familiarity with wide
range of Public Health data sources,
Benchmarking and comparison tools (e.g.
NHS Atlas of Variation, NCHOD, Local
tools). (Provenance: CH181011)
D1.08: Dynamic ethnicity data analysis
across all aspects of care. Wider equality
indicators including disability, sexual
orientation etc (Provenance: HB)
D1.09: Data on wider determinants, social
service, HPA (Provenance: HB)
D1.10: Predictive disease monitoring
(Provenance: WS270911)
(Provenance: AF)
Q8.01: Are our strategic
objectives aligned across
the health economy inc
social care?
Q8.02: What will be the
impact of demographic and
disease pattern change?
Q8.03: How can we make
QIPP savings of £XXXm?
Provenance: HB
Provenance: WS270911
Provenance: HB
Q1.01: How healthy/
unhealthy is my
population relative to
benchmarks?
Q1.02: What health
conditions are changing
most?
Q1.03: Who is at greatest
risk of disease/acute
admission to hospital?
Provenance: AF/WS290911
Provenance: V10
Provenance: AF/WS290911
Provenance: HB
Provenance: HB
Types of Services
Q8.09: What barriers
exist that prevent change
(e.g. org/cultural)?
Provenance: WS270911
Q1.05: What diseases kill
most people and which
are the biggest burden?
Q1.06: Who are the
sickest people and where
do they live?
Provenance: AF
Provenance: WS270911
Provenance: AF
Q1.07: Who would benefit
most from a disease
management programme?
(Provenance: AF)
S7.05: Providing comparative outcome
monitoring inc Patient and Public Data
(Provenance: HB)
S7.06: Production of Board level reports,
presentations and profiles (Provenance: CH181011)
Q8.10: Are our
investments distributed
across all sectors to best
meet the needs of our
population?
Q7.01: When a service
change is implemented,
what was the outcome,
cost and quality for this
and to other services?
Provenance: WS270911
AF)
Q7.08: Did we meet
our targets and can
we sustain them?
Q7.03: What's the
combined impact of all
our interventions for
patients, the services &
health economy?
D7.02: Activity & cost baseline and
tracking data (Provenance: AF)
D7.03: Impact analysis & evaluation
using statistical tools (Provenance: AF)
Q7.09: What are the
benefits of the
embedded in the cycle of
continuous improvement to
improve patient experience
Provenance: HB
Types of Services
S6.03: System-wide activity & cost
modelling (Provenance: AF)
S6.06: Review evidence base (e.g.
National Comparators, NICE, etc)
Q6.01: What would be the
impact, in activity flows and
costs, of making a proposed
change to a clinical pathway?
S6.07: Capture & manage
stakeholder feedback/outcomes
6. How could
things be better?
Q6.07: What are
our drivers for
change and have
we engaged with
stakeholders (inc
Patients)
Provenance: AF
Q6.02: What will be the
combined impact, in cost
and activity, of a whole set
of service changes and
productivity measures?
(Provenance: V13)
Developing new pathways and/
or decommissioning services to
improve safety, quality,
effectiveness of care and
maximise financial benefit
Provenance: WS270911
What
questions
do we
need to
answer?
2. What's really
happening in this
system?
Information available at right time
and to the right person to protect
the vulnerable and ensure the right
care is given to reduce duplication
and improve integration of care
Q6.06: How do we
compare with
evidence and
guidance for process,
outcomes and patient
experience?
Q6.03: Would 'Scenario A'
improve patient flows and
productivity more than
Tools/Data
'Scenario B'?
5. Are my
providers
delivering what
they agreed?
Provenance: HB
Provenance: AF
(Provenance: WS270911)
D6.07: Data outputs from all other
dimensions (as appropriate) (Provenance:
Q6.05: Do we need to
procure services from
alternative providers, or
work in partnership with
other stakeholders to be
more efficient for
provision and
procurement?
Improve commissioning
decisions through better
information and information
analysis
D6.08: Stakeholder feedback
including external sources such as
Social Media and Public Enquiries
D6.09: Staff surveys, appraisals,
complaints, incidents and SUIs (Provenance:
3. How Much?
Provenance: AF/WS290911
Provenance: AF
Provenance: V13
Provenance: WS021211
4. How do we
Compare?
S5.05: Contract development (Provenance: MT)
S5.06: Performance Management and support for
service improvement (inc Negative impacts and
Data Management) (Provenance: MT)
S5.07: Utilisation reviews, PbR Audits, Clinical
Decision Support (Provenance: WS290911)
S5.08: Basic budget reporting (Provenance: CH181011)
S5.09: Contract validation, challenge (Provenance: CH181011)
S5.10: SUS validation with GP Practice Systems
Q3.02: How much do
individual service- lines/
pathways cost compared
to budget?
Q3.03: Is cost aligned to
volume, quality and
outcome?
Types of Services
S3.01: Service-level costing (e.g. by
Specialty, HRG chapter, Diagnostic
chapter) (Provenance: AF)
S3.02: Budget planning, development &
forecasting (Provenance: AF/WS290911)
S3.03: Budget Reporting & Variance
analysis (Provenance: AF)
S3.04: Price verification (provider
costings) & reconciliation to contract,
automated invoice validation (Provenance: AF/CCG)
S3.05: Comparative Provider cost
analysis (Provenance: AF)
Provenance: V13
Challenge our current state
through proactive benchmarking
and comparison in order to
improve clinical outcomes
Q3.09: How much are we
spending on inequalities?
Provenance: WS290911
Q3.04: Are we
maximising value for
money? (e.g. community
provision vs. acute care)
Tools/Data
D3.02: Current and historic Provider
Activity and Cost data-sets (SUS & Local
Contract Mgmt systems) (Provenance: V10)
Q4.01: Where is there
clinical / activity / cost /
outcome variation vs local,
national, international, best
practice?
Q5.06: Can we distinguish
between Provider 'pull'
and Primary Care 'Push'
Tools/Data
D5.01: Data warehouse integration and
reconciliation of Activity/Cost and Provider
contracting reports (Provenance: AF)
D5.02: Contract Monitoring reporting by
Provider (Provenance: CH181011)
D5.05: LA, Primary care and Voluntary/third
sector (Provenance: WS270911)
D5.06: Referral Data
(Provenance: CH181011)
D5.07: CQUINS (Provenance: CH181011)
D5.08: Insight into provider sustainability
(Provenance: V10)
D5.09: Patient Feedback (Provenance: V12)
Q4.02: Are we delivering
national standards of care
for: patient experience,
quality and outcomes?
D3.03: Tariff / Pricing tables, PBR rules
and algorithms (local and national),
Prescribing costs (Provenance: CH181011)
D3.05: Robust timely referral activity
Provenance: AF/WS290911
(Provenance: WS290911)
D3.06: Referral templates with expected
costs (Provenance: CH181011)
D3.07: Reference Cost Data (Provenance: CH181011)
Q4.05: How do we compare
for value for money, outcomes
and productivity against
similar areas/ best practice
over time?
Q4.04: Do current
pathways reflect
evidence-based good
practice?
Provenance: AF
Provenance: AF/WS290911
Provenance: V13
Types of Services
Tools/Data
S4.01: Practice level, regional, and national
benchmarking of disease prevalence, activity,
productivity and costs. (Provenance: AF)
D4.01: Age-sex-deprivation standardised comparative
data at Practice level for commissioned activity (inc
practice specialism). (Provenance: AF)
D4.02: Primary Care data extracts providing integrated
analysis with Acute activity, e.g. prevalence rates vs.
Admissions. (Provenance: AF)
Provenance: CCG
S5.04: Provider level-analysis of ‘how much’ and
‘how good’? (Provenance: AF)
Q3.01: How much is my
budget? How much am I
spending compared to
plan?
Provenance: AF/WS290911
Q3.08: What is the
projected liability for our
referred population?
Q5.07: Are Providers
sending datasets to agreed
standards and frequency?
(If not, are there sanctions
in place?)
Types of Services
S5.03: Invoice validation, challenge (Provenance: CH181011)
Provenance: AF
Provenance: WS270911
Q5.04: What service lines
are above or below plan why?
Management?
S5.01: Analytical support to Contract monitoring &
analysis (Provenance: AF)
S5.02: Provider activity validation & Data Quality
review (Provenance: AF)
amount?
Q3.07: Where are the
most severe cost
pressures?
Local
Authority Core
Offer
D3.01: SUS reporting & analysis webservice, including Budget reports. (Provenance:
challenge?
Provenance: V13
Provenance: V12
Q3.06: Is activity being
priced at the correct
Improved financial information
(including budgeting and planning)
to ensure resource is given to
appropriate care provider for the
treatment given and ultimately
there is better transparency of
financial flows to support improved
commissioning decisions
(Provenance: WS021211)
Provenance: AF
V10)
Q5.02: What elements of
the billed activity can we
Q5.05: Are providers
overlooking agreements
on Threshold
Q5.08: Do our provider
contracts reflect patient
requirements?
Provenance: AF
Q2.06: How much
random variation in
activity do we observe?
Provenance: V13
V10)
D6.10: External information e.g.
Market intelligence (Provenance: V13)
Provenance: AF/WS290911
Q2.05: Where are the
bottlenecks?
Provenance: AF
Q5.03: Are providers
delivering on serviceimprovement, quality
(cquins) patient experience
and waiting-times targets?
(Provenance: V10)
D2.03: Current, historic and planned Provider
Activity and Cost data-sets (SUS & Local Contract
Mgmt Systems e.g. Maternity, Mental Health,
Local Auth etc) (Provenance: V10)
D2.05: Waiting times/list data (Provenance: AF)
D2.06: Patient level datasets with updates inc:
decisions made in secondary care – reasons for
treatment/changes/referrals/delays /test results
and outcomes (Provenance: HB)
D2.07: External Sources such as Social Media
Q5.01: What is the
current performance
against plan?
Provenance: MT/HB/WSS290911
CH181011)
D2.02: SUS data, including acute activity & costs,
referrals with clinical reason, CAB, 'PatientJourney' analysis. (Provenance: CH181011)
Provenance: AF
(Provenance: AF/HB)
D6.03: Forecast analysis and planning
projections (Provenance: AF/HB)
D6.04: Service structure audit and
improvement support. (Provenance: AF/HB)
D6.05: Prescribing decision support
data (Provenance: HB)
D6.06: Capture & processing of
patient experience and outcomes
throughout pathways, inc PROMS
decisions about
their care?
Provenance: AF
S6.08: Clinical governance and
complaints handling (Provenance: V10)
D6.01: Pathway data (Provenance: AF)
D6.02: Contract activity and cost
Q2.10: To what
degree are
patients able to
make informed
Provenance: CCG
Provenance: AF
(Provenance: WS290911)
Tools/Data
D2.01: Near/real time information - activity &
financial for A&E, OOHs, MIU, Acute and
Community Admissions etc (Provenance: CH181011)
Provenance: AF
Provenance: CCG
7. What difference
have we made?
Ensuring patient feedback is
changes?
Provenance: WS290911
Provenance: HB
S2.13: Track patient experience (Provenance: CH181011)
Q2.04: What are the
current flows and
pathways and are
patients using the
right ones?
Q2.09: What is the
impact of patient choice
on Provider volumes?
Provenance: V12
Provenance: HB
Q7.06: Have we
reduced inequalities?
S2.12: Management of Urgent Care Monitoring/
Dashboards (Provenance: CH181011)
Q2.03: Is demand
really going up? By
how much?
Q2.07: What is the
demand today for urgent
care, and who do I need
to target to keep out of
hospital?
Provenance: AF
Q7.07: How did our patients
rate their experience of our
services?
S6.01: Pathway & scenario modelling
(inc Audit of Admission thresholds
and service structure) (Provenance: AF)
S6.02: Contract modelling (Provenance: AF)
(Provenance: WS290911)
1. How Healthy?
Reducing health inequalities and
improving health outcomes now
and in the future
Q7.10: What is the
impact of change on
other services &
stakeholders?
Q7.05: Have we
improved outcomes?
D7.06: Data outputs from all other
dimensions (as appropriate) (Provenance: CH181011)
D7.07: Data required for Programme Gov
inc Benefits Mgmt, Plans etc (Provenance: CH181011)
Provenance: AF
Q2.02: How long are
patients waiting for
treatment?
Provenance: AF
Provenance: HB
Provenance: AF/WS290911
D7.05: Public Health Observatory tools
including survey tools (Provenance: HB)
Reduce unmet need by
anticipating future priorities and
improving decisions about
resource allocation, by ensuring
planned services reflect changing
needs and demands of local
population
(Provenance: HB)
S2.09: Indicators to track progress throughout
pathways reasons/decisions for referrals, patient
experience and outcomes.
pressures?
Provenance: WS270911
Provenance: AF
Tools/Data
D7.01: Performance & Public Health
metrics, frameworks and dashboards
(Provenance: AF)
Provenance: WS270911
8. What are our
future plans?
S2.07: Provide access to patient medical records
Q2.01: Why have we
got financial
Q1.10: What are the
preventable conditions
contributing to our
premature mortality?
Q1.09: What proportion
of disease is avoidable?
Provenance: CH181011
Provenance: AF/HB/WS290911
Q7.02: Can I isolate the
'cause and effect' of an
individual initiative?
(Provenance: CH181011)
Types of Services
S2.01: Trend and statistical analysis (activity,
cost, SPC) (Provenance: AF)
S2.02: Capacity and demand analysis, patient
flow modelling, waiting times analysis (Provenance: AF)
S2.05: Analytics support to Clinical audit. (Provenance:
Q1.08: What causes
patients most distress?
Provenance: AF
Provenance: WS290911
S7.03: Metrics reporting. (Provenance: AF)
Intelligence
for
Commissioner
Q1.04: How is the local
population going to
change in future?
Provenance: HB
Q8.07: Have we got the
balance correct between
national, local and patient
expectations?
S7.01: Programme and project
monitoring. (Provenance: AF)
S7.02: Providing comparative cost and
activity monitoring (Provenance: AF)
S7.04: Performance reporting.
Q8.06: What activity
should we contract for to
deliver the service
changes / cost efficiencies
needed?
Q8.05: Given our budget,
how can we decide how
much to invest/disinvest in
services?
Q8.04: How will
changes in technologies
(IT, drugs etc) impact
us?
Overarching
Concepts
O0.01 Interpretation, contextualisation,
exploitation and stakeholder communication
O0.02 Data collected at patient level
O0.03 Holistic Analyses - Full System view rather
than isolated segments
O0.04 Flexible tariffs
O0.05 Master Data Administration (inc Common
currencies & agreed standardisation techniques)
O0.06 Timeliness and quality of data
O0.07 Data definitions and standards
O0.08 Interoperability
O0.09 Knowledge Management
O0.10 Integrated ways of working
O0.11 Development of Metrics
O0.12 Simplify presentation appropriate to
audience
S4.02: Analysis and presentation of
productivity indicators by programme /
project. (Provenance: AF)
S4.03: Clinical Pathway mapping and
modelling and cost comparators (Provenance: AF/
WS290911)
S4.04: Providing evidence and information on
comparative health outcomes. (Provenance: AF/WS290911)
S4.05: Statistical analysis of variation and
correlations e.g. Statistical Process Control
(Provenance: CH181011)
D4.03: Comparative benchmarking tools (e.g. QOF
Data sets, NHS Comparators, NHS Atlas of Variation,
Better Care Better Value indicators). (Provenance: CH181011)
D4.05: Benchmarked GP referrals analysis. (Provenance: AF/HB)
D4.06: Practice profiles (Needing national standards)
(Provenance: HB)
D4.07: National Guidance, PROMS, Utilisation reviews
(Provenance: CH181011)
Filename: Commissioning Intelligence Model V13.vsd
Version Date
Comment
1.
Aug 11 Original from Andrew Fenton
2.
15/9/11 Added comments from Ming Tang, Helen Brown and responses to the IFC
document
3.
21/9/11 Added comments from Shahid Ali and benefits from Jo Butterfield
4.
27/9/11 Tidied version for workshops
5
28/9/11 With comments from London Workshop
6.
14/10/11 Added comments from workshop and consultation feedback
7.
19/10/11 After linking data to services (CH & HB)
8.
28/11/11 Q8.3 to include QIPP
9.
5/12/11 Amendments after CSO workshop on 2/12/11
10.
9/12/11 Amendments after ref group review
Version
11.
12.
13.
Date
Comment
14/12/11 Amendments to support Business Analysis Team
14/12/11 Further amendments after CSO workshop on 2/12/11
19/1/12 Text changes from Gavin McIntosh
Draft for Discussion Only
Commissioning
Support
Development
All using The
Commissioning
6
Intelligence Model
Producing joint report
July 2012
Proposed Commissioning Intelligence Delivery Model
National Bodies
Sub-national
National
incl: NHSCB ( 4 Regional Teams with 27 Local Area Teams (LATs))
PHE, Research, Commercial, CQC, Monitor & Public
National Data Feeds
IC
Local & National Data Feeds
DMIC x ~10
DMICs may also
provide data
to wider stakeholders
Safe haven
Small no CCGs
doing own
intelligence
Local
Data Flows
Safe haven
CCGs
CCG
x~210
CSS
X~25
Work is ongoing to
understand the
data
accountabilities
and
responsibilities
for each type
of organisation
and how data
will flow
LAPH
CCG
X~150
7
A potential future view – Repeated Data Management
PHE data e.g. Cancer, Drugs data & Summarised Reports
Locally defined data e.g. diagnostics/tariffs
National data from e.g. IC/SUS/GPES
PH Data
Management
Duplicated, potentially inconsistent, uneconomic
Duplicated
PH
Advocacy
CCGs
~270
CSSs ~25
Health & Wellbeing Boards
LA ~150
PH Insight
Insight
Data
Management
National data from e.g. IC/SUS/GPES
Data Management
Integration Centres
Locally defined data e.g. diagnostics/tariffs
CSS Development Timetable
CSS Process to Date
Dec 11 – Mar 12
CP 1
National Scale
Program offers Stages
co-design
Assessment
Steps
Apr 12 – Aug 12
CP 2
Sep 12 – Apr 13
CP 3
CSS fully
launched
Set up planning &
Development for ‘scale
CSS’
Establish and embed
‘scale CSS’
Scale CSS
Selection
Additional Tests
Development
Plans
Scale CSS Technical
accreditation
programme
Activities
• Co-design group
established
• Costing assumptions for
CP2
• Transition model to be
agreed
• Investment plan sign off
• Transition planning
• Gap analysis
• Local agreements &
SLA development
•
•
•
•
Implementation
Risk management
Monitoring & accreditation
System review
Why do it – what problem are we trying to address?
Why do it – what problem are we trying to address?
1. Overcoming the variation and inconsistencies in how
Commissioning data in the NHS is handled – STANDARDS
2. Dealing with variable efficiencies / value for money in NHS data
management for commissioning support – COSTS
3. Ensuring a technical architecture that enables delivery of
commissioning intelligence – BUSINESS FUNCTION
4. A technical architecture that is flexible and responsive to
changing requirements over time - SUSTAINABILITY
1
0
Discussion points :
Why do it – what problem are we trying to address?
PH Questions
1. How will PH get access to data in the future?
2. What infrastructure is required? N3?
3. Will we be charged for this?
4. How should we get started in working with our local CSS?
CSS / DMIC Questions?
1. What are the requirements for PH?
2. How will we fund activities not commissioned by CCGs?
3. How will PH gain CCG approval for use of their data?
4. What value add services would you be interested in?
5. How can we make sure we make best use of available resources
1
within the local Health Economy?
1